Sanjeev H Kothari

age ~56

from Foster City, CA

Get Report

Also known as:

Sanjeev A Kothari
Sanjeew Kothari
Sanjeev Kotha

Phone and address:: 360 Menhaden Ct, San Mateo, CA 94404

Connected to:

Sanjeev Kothari Phones & Addresses

360 Menhaden Ct, San Mateo, CA 94404
Foster City, CA
2 Regency Ct, Exton, PA 19341 • (610)2963217
Wilmington, DE
Princeton, NJ
Coralville, IA
North Brunswick, NJ
Chester, PA
842 Magellan Ln, Foster City, CA 94404

Work

Company:

Genentech
Sep 2010
Position:

Senior scientific manager

Education

Degree:

Ph.D.
School / High School:

University of Iowa
1993 to 1998
Specialities:

Pharmaceutics

Awards

Several AstraZenca Excellence awards for delivering workshops such as: a roller compaction (including modeling) workshop in April 2008 and a leadership capabilities workshop in June 2008, • Ondetti and Cushman Innovation Award (November 2003) for discovery of a novel platform technology for orally disintegrating tablets. This is the highest level discovery award at Bristol-Myers Squibb that honors work that can make a significant scientific and economic impact for Bristol-Myers Squibb. • Five Bristol-Myers Squibb Star Awards for collaborative work, driving performance and direct communication on several high-priority projects. • Bristol-Myers Squibb-Excellence Award for the year 2000.

Industries

Pharmaceuticals

Us Patents

Pharmaceutical Composition
view source
US Patent:

8632807, Jan 21, 2014
Filed:

May 18, 2012
Appl. No.:

13/475525
Inventors:

Joseph Richard Creekmore - Wilmington DE, US
Sanjeev Hukmichand Kothari - Wilmington DE, US
Bradford J. Mueller - Wilmington DE, US
Yingxu Peng - Wilmington DE, US
Assignee:

AstraZeneca UK Limited - London
International Classification:

A61K 9/32
A61K 31/505
A61K 9/36
US Classification:

424480, 424494, 424497, 514275
Abstract:

The invention relates to pharmaceutical compositions containing rosuvastatin calcium of formula (I) and processes for their manufacture.

Flashmelt Oral Dosage Formulation
view source
US Patent:

20020076437, Jun 20, 2002
Filed:

Oct 9, 2001
Appl. No.:

09/973226
Inventors:

Sanjeev Kothari - Princeton NJ, US
Divyakant Desai - West Windsor NJ, US
International Classification:

A61K009/14
A61K009/20
A61K031/47
A61K031/225
US Classification:

424/465000, 514/019000, 514/312000, 514/547000
Abstract:

There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.

Control Of Compactibility Through Cystallization
view source
US Patent:

20040175419, Sep 9, 2004
Filed:

Apr 19, 2004
Appl. No.:

10/475959
Inventors:

Omar Sprockel - Bridgewater NJ, US
Chiajen Lai - Kendall Park NJ, US
Robert Discordia - Pennington NJ, US
Chenkou Wei - Prnceton Junction NJ, US
Sanjeev Kothari - Princeton NJ, US
Soojin Kim - West Orange NJ, US
International Classification:

A61K009/20
US Classification:

424/465000
Abstract:

The invention is directed toward a method for increasing the compactability of an active ingredient by determining the crystallization parameters of the active ingredient that affect compactability; and controlling the crystallization parameters to achieve increased compactability.

Pharmaceutical Tablet Having A High Api Content
view source
US Patent:

20040208924, Oct 21, 2004
Filed:

May 24, 2004
Appl. No.:

10/476047
Inventors:

Omar Sprockel - Bridgewater NJ, US
Chiajen Lai - Kendall Park NJ, US
Chenkou Wei - Princeton Junction NJ, US
Sanjeev Kothari - Princeton NJ, US
Robert Discordia - Pennington NJ, US
Soojin Kim - West Orange NJ, US
International Classification:

A61K038/04
A61K031/44
A61K031/16
A61K031/40
US Classification:

424/464000, 514/019000, 514/357000, 514/408000, 514/616000
Abstract:

The invention is directed toward a tablet containing an unusually high percentage of an active ingredient in proportion to exipients.

Sustained Release Drug Delivery System And Method
view source
US Patent:

20060099254, May 11, 2006
Filed:

Nov 2, 2005
Appl. No.:

11/266516
Inventors:

Divyakant Desai - West Windsor NJ, US
Sanjeev Kothari - Princeton NJ, US
Laxmikant Sharma - Indianapolis IN, US
International Classification:

A61K 31/522
A61K 9/22
A61K 31/16
A61K 31/175
US Classification:

424468000, 514263340, 514592000, 514629000
Abstract:

The present invention relates to a pharmaceutical delivery system comprising a gel-like structure that comprises at least one water-soluble polymer, such as, for example, povidone or hydroxypropyl cellulose, and at least one fatty acid, such as, for example, stearic acid or lauric acid. The invention further relates to a sustained release drug delivery composition comprising the gel-like structure and at least one drug trapped or dissolved therein, wherein said system is capable of releasing the drug in a dissolution medium at a controlled rate. The invention is also directed to a method for preparing the sustained release drug delivery composition.

Flashmelt Oral Dosage Formulation
view source
US Patent:

20070275059, Nov 29, 2007
Filed:

Nov 2, 2004
Appl. No.:

10/979556
Inventors:

Sanjeev Kothari - Princeton NJ, US
Divyakant Desai - West Windsor NJ, US
International Classification:

A61K 9/62
A61K 31/225
A61K 31/401
A61K 31/497
A61K 31/52
US Classification:

424465000, 514209000, 514253080, 514263400, 514423000, 514510000
Abstract:

There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.

Flashmelt Oral Dosage Formulation
view source
US Patent:

20100016448, Jan 21, 2010
Filed:

Sep 14, 2009
Appl. No.:

12/558813
Inventors:

SANJEEV KOTHARI - Princeton NJ, US
DIVYAKANT S. DESAI - West Windsor NJ, US
International Classification:

A61K 47/00
US Classification:

514770
Abstract:

There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.

Flashmelt Oral Dosage Formulation
view source
US Patent:

20110217342, Sep 8, 2011
Filed:

May 16, 2011
Appl. No.:

13/108193
Inventors:

Sanjeev Kothari - Princeton NJ, US
Divyakant Desai - West Windsor NJ, US
International Classification:

A61K 9/00
A61K 31/496
US Classification:

424400, 51425307
Abstract:

There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.

Resumes

Senior Scientific Manager At Genentech

view source

Position:

Senior Scientific Manager at Genentech

Location:

San Francisco Bay Area

Industry:

Pharmaceuticals

Work:

Genentech since Sep 2010
Senior Scientific Manager
AAPS MSE Subgroup 2009 - 2010
Committee Member
AstraZeneca Oct 2007 - Sep 2010
Team Manager, Product Development (Material Science and Process Engineering)
BMS 1998 - 2007
Senior Research Investigator
Bristol-Myers Squibb (New Brunswick, NJ) 1998 - 2007
Research Investigator I and II; Senior Research Investigator I and II

Education:

University of Iowa 1993 - 1998
Ph.D., Pharmaceutics University of Pune 1986 - 1990
B.Pharm, Pharmacy St. Vincents

Honor & Awards:

• Several AstraZenca Excellence awards for delivering workshops such as: a roller compaction (including modeling) workshop in April 2008 and a leadership capabilities workshop in June 2008, • Ondetti and Cushman Innovation Award (November 2003) for discovery of a novel platform technology for orally disintegrating tablets. This is the highest level discovery award at Bristol-Myers Squibb that honors work that can make a significant scientific and economic impact for Bristol-Myers Squibb. • Five Bristol-Myers Squibb Star Awards for collaborative work, driving performance and direct communication on several high-priority projects. • Bristol-Myers Squibb-Excellence Award for the year 2000.